Benzinga

MAY 16, 2023

Federal Trade Commission would sue to stop Amgen Inc's (NASDAQ: AMGN ) $28 billion takeover of Horizon Therapeutics PLC (NASDAQ: HZNP ).

52

52

Benzinga

NOVEMBER 30, 2022

Horizon Therapeutics Plc (NASDAQ: HZNP ) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN ), Janssen Global Service , and Sanofi SA (NASDAQ: SNY ) on potential takeover offers for the company. According to a statement, there is no certainty that an offer for the company will be made.

Marketability 52

Marketability 52

Business Wire M&A

MAY 16, 2023

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today issued the following statement in response to the FTC’s complaint seeking to block Amgen’s proposed acquisition of the Company: “This acquisition has the potential to accelerate the availability of important rare disease medicines to more patients worldwide.

52

52

Law 360 M&A

JANUARY 31, 2023

biotechnology company Amgen Inc. and Ireland-based drugmaker Horizon Therapeutics PLC revealed in filings with the U.S. Securities and Exchange Commission on Monday that the Federal Trade Commission is reviewing their proposed $28 billion merger.

40

40

Law 360 M&A

JANUARY 5, 2023

Biopharmaceutical company Horizon Therapeutics PLC and the members of its board have been hit with a shareholder suit alleging they failed to supply investors with critical information about its proposed $27.8 billion acquisition by Amgen Inc.

40

40

Benzinga

NOVEMBER 30, 2022

Horizon Therapeutics Plc (NASDAQ: HZNP ) confirmed it's engaged in preliminary talks with Amgen Inc (NASDAQ: AMGN ), Janssen Global Service , and Sanofi SA SNY on potential takeover offers for the company. SVB Leerink projects 2023 revenue of $4.0 billion, adj operating income of $1.6 billion, and EPS of $5.51.

52

52

Benzinga

DECEMBER 13, 2022

When companies start buying each other at a big premium to what the market’s willing to pay, it tells you that stocks entirely, the whole market, may just be too cheap,” Cramer said, according to the report. NASDAQ: AMGN ) has agreed to buy Horizon Therapeutics PLC (NASDAQ: HZNP ) at an enterprise value of approximately $28.3

Enterprise Value 52

Enterprise Value Marketability 52

Benzinga

MAY 26, 2022

was bought by Horizon Therapeutics plc to bolster the company's portfolio, pipeline, and therapeutic emphasis on rare illness medicines. Furthermore, the demand for innovative therapeutics is increasing with the rising diagnosis rate and favorable reimbursement schemes for the situation.

Marketability 40

Marketability 40

Benzinga

JUNE 9, 2022

NASDAQ: EGRX ) ("Eagle" or the "Company") today announced it has completed the acquisition of the entire issued share capital of Acacia Pharma Group plc ("Acacia Pharma") (EURONEXT: ACPH) by way of a scheme of arrangement under Part 26 of the United Kingdom's Companies Act 2006 (the "Transaction"). WOODCLIFF LAKE, N.J.,

Marketability 40

Marketability 40

Reynolds Holding

OCTOBER 5, 2022

Although it has been a relatively quiet first half of 2022 for securities litigators in the Supreme Court, one decision has a potential impact on rulemaking and several other decisions could be on the horizon. Lucia Companies, Inc. UIP Companies, Inc. On November 7, 2022, the Supreme Court will hear argument in SEC v.

Start-ups 72

Start-ups Marketability Equity Compliance 72